{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:56:51Z","timestamp":1785740211908,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cartilage engineering that combines competent seeding cells and a compatible scaffold is increasingly gaining popularity and is potentially useful for the treatment of various bone and cartilage diseases. Intensive efforts have been made by researchers to improve the viability and functionality of seeding cells of engineered constructs that are implanted into damaged cartilage. Here, we designed an integrative system combining gene engineering and the controlled-release concept to solve the problems of both seeding cell viability and functionality through precisely regulating the anti-apoptotic gene bcl-2 in the short-term and the chondrogenic master regulator Sox9 in the long-term. Both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experiments demonstrated that our system enhances the cell viability and chondrogenic effects of the engineered scaffold after introduction of the system while restricting anti-apoptotic gene expression to only the early stage, thereby preventing potential oncogenic and overdose effects. Our system was designed to be modular and can also be readily adapted to other tissue engineering applications with minor modification.<\/jats:p>","DOI":"10.1038\/srep26617","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T09:24:27Z","timestamp":1464168267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A controlled double-duration inducible gene expression system for cartilage tissue engineering"],"prefix":"10.1038","volume":"6","author":[{"given":"Ying","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daixu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"BFsrep26617_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1126\/science.1069210","volume":"295","author":"LG Griffith","year":"2002","unstructured":"Griffith, L. G. & Naughton, G. Tissue engineering\u2013current challenges and expanding opportunities. Science 295, 1009\u201314 (2002).","journal-title":"Science"},{"key":"BFsrep26617_CR2","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1089\/ten.2006.12.1699","volume":"12","author":"PJ Emans","year":"2006","unstructured":"Emans, P. J. et al. Differential cell viability of chondrocytes and progenitor cells in tissue-engineered constructs following implantation into osteochondral defects. Tissue Eng 12, 1699\u2013709 (2006).","journal-title":"Tissue Eng"},{"key":"BFsrep26617_CR3","doi-asserted-by":"publisher","first-page":"e27064","DOI":"10.1371\/journal.pone.0027064","volume":"6","author":"Q Wei","year":"2011","unstructured":"Wei, Q., Hariharan, V. & Huang, H. Cell-cell contact preserves cell viability via plakoglobin. PLoS One 6, e27064 (2011).","journal-title":"PLoS One"},{"key":"BFsrep26617_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1582-4934.2007.00027.x","volume":"11","author":"O Bleiziffer","year":"2007","unstructured":"Bleiziffer, O., Eriksson, E., Yao, F., Horch, R. E. & Kneser, U. Gene transfer strategies in tissue engineering. J Cell Mol Med 11, 206\u201323 (2007).","journal-title":"J Cell Mol Med"},{"key":"BFsrep26617_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11926-014-0450-7","volume":"16","author":"H Madry","year":"2014","unstructured":"Madry, H. & Cucchiarini, M. Tissue-engineering strategies to repair joint tissue in osteoarthritis: nonviral gene-transfer approaches. Curr Rheumatol Rep 16, 450 (2014).","journal-title":"Curr Rheumatol Rep"},{"key":"BFsrep26617_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11926-014-0449-0","volume":"16","author":"M Cucchiarini","year":"2014","unstructured":"Cucchiarini, M. & Madry, H. Use of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches. Curr Rheumatol Rep 16, 449 (2014).","journal-title":"Curr Rheumatol Rep"},{"key":"BFsrep26617_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.arcmed.2008.02.007","volume":"39","author":"GM Bran","year":"2008","unstructured":"Bran, G. M., Stern-Straeter, J., Hormann, K., Riedel, F. & Goessler, U. R. Apoptosis in bone for tissue engineering. Arch Med Res 39, 467\u201382 (2008).","journal-title":"Arch Med Res"},{"key":"BFsrep26617_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0169-409X(98)00023-4","volume":"33","author":"AG Mikos","year":"1998","unstructured":"Mikos, A. G., McIntire, L. V., Anderson, J. M. & Babensee, J. E. Host response to tissue engineered devices. Adv Drug Deliv Rev 33, 111\u2013139 (1998).","journal-title":"Adv Drug Deliv Rev"},{"key":"BFsrep26617_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/ten.tea.2011.0315","volume":"18","author":"Z Yang","year":"2012","unstructured":"Yang, Z. et al. Improved mesenchymal stem cells attachment and in vitro cartilage tissue formation on chitosan-modified poly(L-lactide-co-epsilon-caprolactone) scaffold. Tissue Eng Part A 18, 242\u201351 (2012).","journal-title":"Tissue Eng Part A"},{"key":"BFsrep26617_CR10","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1002\/adma.200900241","volume":"21","author":"P Tayalia","year":"2009","unstructured":"Tayalia, P. & Mooney, D. J. Controlled growth factor delivery for tissue engineering. Adv Mater 21, 3269\u201385 (2009).","journal-title":"Adv Mater"},{"key":"BFsrep26617_CR11","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1089\/ten.tea.2013.0358","volume":"20","author":"D Suarez-Gonzalez","year":"2014","unstructured":"Suarez-Gonzalez, D. et al. Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity. Tissue Eng Part A 20, 2077\u201387 (2014).","journal-title":"Tissue Eng Part A"},{"key":"BFsrep26617_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/gt.2011.20","volume":"18","author":"TA Fuchsluger","year":"2011","unstructured":"Fuchsluger, T. A., Jurkunas, U., Kazlauskas, A. & Dana, R. Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage. Gene Ther 18, 778\u201387 (2011).","journal-title":"Gene Ther"},{"key":"BFsrep26617_CR13","doi-asserted-by":"publisher","first-page":"P211","DOI":"10.1016\/j.otohns.2004.06.127","volume":"131","author":"JP O Neal","year":"2004","unstructured":"O Neal, J. P., Pellitteri, P. K., Carey, D. J. & Barth, P. C. Expression of the anti-apoptotic gene survivin in human medullary thyroid carcinoma tissue. Otolaryngology - Head and Neck Surgery 131, P211 (2004).","journal-title":"Otolaryngology - Head and Neck Surgery"},{"key":"BFsrep26617_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbamcr.2010.10.010","volume":"1813","author":"L Portt","year":"2011","unstructured":"Portt, L., Norman, G., Clapp, C., Greenwood, M. & Greenwood, M. T. Anti-apoptosis and cell survival: a review. Biochim Biophys Acta 1813, 238\u201359 (2011).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep26617_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/336259a0","volume":"336","author":"JC Reed","year":"1988","unstructured":"Reed, J. C., Cuddy, M., Slabiak, T., Croce, C. M. & Nowell, P. C. Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 336, 259\u201361 (1988).","journal-title":"Nature"},{"key":"BFsrep26617_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-1-60761-999-4_20","volume":"698","author":"LA Solchaga","year":"2011","unstructured":"Solchaga, L. A., Penick, K. J. & Welter, J. F. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol 698, 253\u201378 (2011).","journal-title":"Methods Mol Biol"},{"key":"BFsrep26617_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/scrt31","volume":"1","author":"S Boeuf","year":"2010","unstructured":"Boeuf, S. & Richter, W. Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther 1, 31 (2010).","journal-title":"Stem Cell Res Ther"},{"key":"BFsrep26617_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijom.2007.11.024","volume":"37","author":"S Sun","year":"2008","unstructured":"Sun, S., Wang, Z. & Hao, Y. Osterix overexpression enhances osteoblast differentiation of muscle satellite cells in vitro . Int J Oral Maxillofac Surg 37, 350\u20136 (2008).","journal-title":"Int J Oral Maxillofac Surg"},{"key":"BFsrep26617_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00223-006-0083-6","volume":"79","author":"X Zhang","year":"2006","unstructured":"Zhang, X. et al. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose\u2013derived stem cells in vitro and in vivo . Calcif Tissue Int 79, 169\u201378 (2006).","journal-title":"Calcif Tissue Int"},{"key":"BFsrep26617_CR20","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.biomaterials.2013.11.043","volume":"35","author":"Y Yao","year":"2014","unstructured":"Yao, Y., He, Y., Guan, Q. & Wu, Q. A tetracycline expression system in combination with Sox9 for cartilage tissue engineering. Biomaterials 35, 1898\u2013906 (2014).","journal-title":"Biomaterials"},{"key":"BFsrep26617_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jconrel.2008.02.012","volume":"128","author":"ML Ho","year":"2008","unstructured":"Ho, M. L. et al. Controlled release carrier of BSA made by W\/O\/W emulsion method containing PLGA and hydroxyapatite. JOURNAL OF CONTROLLED RELEASE 128, 142\u2013148 (2008).","journal-title":"JOURNAL OF CONTROLLED RELEASE"},{"key":"BFsrep26617_CR22","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1073\/pnas.1220108110","volume":"110","author":"C Scotti","year":"2013","unstructured":"Scotti, C. et al. Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci USA 110, 3997\u20134002 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep26617_CR23","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.biomaterials.2008.03.021","volume":"29","author":"Y Wang","year":"2008","unstructured":"Wang, Y., Bian, Y. Z., Wu, Q. & Chen, G. Q. Evaluation of three-dimensional scaffolds prepared from poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for growth of allogeneic chondrocytes for cartilage repair in rabbits. Biomaterials 29, 2858\u201368 (2008).","journal-title":"Biomaterials"},{"key":"BFsrep26617_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/335563a0","volume":"335","author":"I Sadowski","year":"1988","unstructured":"Sadowski, I., Ma, J., Triezenberg, S. & Ptashne, M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563\u20134 (1988).","journal-title":"Nature"},{"key":"BFsrep26617_CR25","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.biomaterials.2013.11.043","volume":"35","author":"Y Yao","year":"2014","unstructured":"Yao, Y., He, Y., Guan, Q. & Wu, Q. A tetracycline expression system in combination with Sox9 for cartilage tissue engineering. Biomaterials 35, 1898\u2013906 (2014).","journal-title":"Biomaterials"},{"key":"BFsrep26617_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.actbio.2011.10.001","volume":"8","author":"J Rui","year":"2012","unstructured":"Rui, J. et al. Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits. Acta Biomater 8, 511\u20138 (2012).","journal-title":"Acta Biomater"},{"key":"BFsrep26617_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","volume":"30","author":"DJ Hines","year":"2013","unstructured":"Hines, D. J. & Kaplan, D. L. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights. Crit Rev Ther Drug Carrier Syst 30, 257\u201376 (2013).","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"BFsrep26617_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.msec.2014.02.014","volume":"39","author":"S Hao","year":"2014","unstructured":"Hao, S. et al. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release. Mater Sci Eng C Mater Biol Appl 39, 113\u20139 (2014).","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"BFsrep26617_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1166\/jbn.2015.1827","volume":"11","author":"W Liu","year":"2015","unstructured":"Liu, W., Wei, J., Wei, Y. & Chen, Y. Controlled Dual Drug Release and In Vitro Cytotoxicity of Electrospun Poly(lactic-co-glycolic acid) Nanofibers Encapsulated with Micelles. J Biomed Nanotechnol 11, 428\u201335 (2015).","journal-title":"J Biomed Nanotechnol"},{"key":"BFsrep26617_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ceb.2006.10.007","volume":"18","author":"Y Kawakami","year":"2006","unstructured":"Kawakami, Y., Rodriguez-Leon, J. & Izpisua, B. J. The role of TGFbetas and Sox9 during limb chondrogenesis. Curr Opin Cell Biol 18, 723\u20139 (2006).","journal-title":"Curr Opin Cell Biol"},{"key":"BFsrep26617_CR31","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1093\/emboj\/17.19.5718","volume":"17","author":"V Lefebvre","year":"1998","unstructured":"Lefebvre, V., Li, P. & de Crombrugghe, B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17, 5718\u201333 (1998).","journal-title":"EMBO J"},{"key":"BFsrep26617_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/104454903321515922","volume":"22","author":"M Kypriotou","year":"2003","unstructured":"Kypriotou, M. et al. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol 22, 119\u201329 (2003).","journal-title":"DNA Cell Biol"},{"key":"BFsrep26617_CR33","first-page":"573","volume":"27","author":"Z Xu","year":"2012","unstructured":"Xu, Z. et al. Role of hypoxia-inducible-1alpha in hepatocellular carcinoma cells using a Tet-on inducible system to regulate its expression in vitro . Oncol Rep 27, 573\u20138 (2012).","journal-title":"Oncol Rep"},{"key":"BFsrep26617_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nmeth846","volume":"3","author":"J Szulc","year":"2006","unstructured":"Szulc, J., Wiznerowicz, M., Sauvain, M. O., Trono, D. & Aebischer, P. A versatile tool for conditional gene expression and knockdown. Nat Methods 3, 109\u201316 (2006).","journal-title":"Nat Methods"},{"key":"BFsrep26617_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s11248-011-9580-0","volume":"21","author":"K Anders","year":"2012","unstructured":"Anders, K., Buschow, C., Charo, J. & Blankenstein, T. Depot formation of doxycycline impairs Tet-regulated gene expression in vivo . Transgenic Res 21, 1099\u2013107 (2012).","journal-title":"Transgenic Res"},{"key":"BFsrep26617_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jneumeth.2013.01.014","volume":"214","author":"T Sato","year":"2013","unstructured":"Sato, T., Muroyama, Y. & Saito, T. Inducible gene expression in postmitotic neurons by an in vivo electroporation-based tetracycline system. J Neurosci Methods 214, 170\u20136 (2013).","journal-title":"J Neurosci Methods"},{"key":"BFsrep26617_CR37","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1089\/104303403322542266","volume":"14","author":"HF Zhao","year":"2003","unstructured":"Zhao, H. F., Boyd, J., Jolicoeur, N. & Shen, S. H. A coumermycin\/novobiocin-regulated gene expression system. Hum Gene Ther 14, 1619\u201329 (2003).","journal-title":"Hum Gene Ther"},{"key":"BFsrep26617_CR38","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/sj.gt.3303034","volume":"14","author":"K Stieger","year":"2007","unstructured":"Stieger, K. et al. Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases. Gene Ther 14, 1668\u201373 (2007).","journal-title":"Gene Ther"},{"key":"BFsrep26617_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejrad.2005.08.008","volume":"57","author":"AJ Freemont","year":"2006","unstructured":"Freemont, A. J. & Hoyland, J. Lineage plasticity and cell biology of fibrocartilage and hyaline cartilage: its significance in cartilage repair and replacement. Eur J Radiol 57, 32\u20136 (2006).","journal-title":"Eur J Radiol"},{"key":"BFsrep26617_CR40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0142-9612(03)00498-8","volume":"25","author":"GG Reinholz","year":"2004","unstructured":"Reinholz, G. G., Lu, L., Saris, D. B., Yaszemski, M. J. & O\u2019Driscoll, S. W. Animal models for cartilage reconstruction. Biomaterials 25, 1511\u201321 (2004).","journal-title":"Biomaterials"},{"key":"BFsrep26617_CR41","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1016\/S0142-9612(00)00121-6","volume":"21","author":"DW Hutmacher","year":"2000","unstructured":"Hutmacher, D. W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21, 2529\u201343 (2000).","journal-title":"Biomaterials"},{"key":"BFsrep26617_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.actbio.2008.07.030","volume":"5","author":"H Tan","year":"2009","unstructured":"Tan, H., Wu, J., Lao, L. & Gao, C. Gelatin\/chitosan\/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering. Acta Biomater 5, 328\u201337 (2009).","journal-title":"Acta Biomater"},{"key":"BFsrep26617_CR43","doi-asserted-by":"publisher","first-page":"15118","DOI":"10.3390\/ijms160715118","volume":"16","author":"DH Rosenzweig","year":"2015","unstructured":"Rosenzweig, D. H., Carelli, E., Steffen, T., Jarzem, P. & Haglund, L. 3D-Printed ABS and PLA Scaffolds for Cartilage and Nucleus Pulposus Tissue Regeneration. Int J Mol Sci 16, 15118\u201335 (2015).","journal-title":"Int J Mol Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep26617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26617","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T04:41:05Z","timestamp":1672893665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep26617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,31]]}},"alternative-id":["BFsrep26617"],"URL":"https:\/\/doi.org\/10.1038\/srep26617","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]},"assertion":[{"value":"26 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26617"}}